Type(s) of Cancer
Lung
Lung
Study Phase
Phase 3
Study Completion Date
April 2012
April 2012
NCT00762034Uploaded 06-19-2015
Available for Download
PDS UID: LungNo_EliLill_2008_141
Randomized, Open-Label, Phase 3 Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer
Files:
PROTOCOLJMHD 05 Protocol (f).pdf
CRFJMHD_CRF_redacted.pdf
DATA DICTIONARYjmhd_specification_final_redacted.pdf
DATA (COMPARATOR ARM)jmhd_deid_control_trt.zip